Evidence map›Paper›PMID 35796947›Full record

ArticleApplied biochemistry and biotechnology2023

Multimode Assessment of Commercial Polyherbal Formulation: an In Vitro and In Silico Approach.

Saptadipa Paul, Mala Majumdar

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Polyherbal Therapeutics Mitigate CClReproductive sciences (Thousand Oaks, Calif.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saptadipa PaulDepartment of Biotechnology, School of Sciences, JAIN (Deemed to Be University), #34,1st Cross, J C Road, Bangalore, 560027, India.ORCID http://orcid.org/0000-0001-9295-6592
Mala MajumdarDepartment of Biotechnology, School of Sciences, JAIN (Deemed to Be University), #34,1st Cross, J C Road, Bangalore, 560027, India. mala.majumdar@jainuniversity.ac.in.ORCID http://orcid.org/0000-0002-4839-5975
Jain University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antidiabetic polyherbal formulations (APH) are used in management of diabetes mellitus (DM). High glucose levels in DM are related to oxidative stress leading to its associated complications. Therefore, assessing antioxidant activity of various APH might unveil an antioxidant-rich formulation for management of DM and its associated complications. Subsequently selecting an antioxidant assessment method is a challenging aspect, considering various in vitro assays working with diverse mechanism of action. Therefore, present study aims to validate the sensitivity/capacity of different antioxidant assay, thereby assessing the antioxidant potential of 9-APH. Obtained results revealed the ABTS·

Indexed as

Diabetes MellitusGlycoside Hydrolase Inhibitorsalpha-AmylasesAntioxidantsBenzothiazolesHumansHypoglycemic AgentsMolecular Docking SimulationPlant ExtractsSulfonic Acids2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acidalpha-AmylasesAntioxidantsBenzothiazolesGlycoside Hydrolase InhibitorsHypoglycemic AgentsPlant ExtractsSulfonic AcidsAntioxidant activityCorrelationDiabetes mellitusMolecular dockingMolecular dynamics simulationPolyherbal formulation

Identifiers

PMID35796947
OpenAlexW4284672864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.